Cyrus Poonawalla Net Worth is one of India’s most prominent entrepreneurs in the global vaccine industry. He founded Serum Institute of India in 1966, growing it into one of the world’s major vaccine manufacturers. Born in Pune in 1941, he came from a family associated with thoroughbred horse breeding before building his career in healthcare. His estimated wealth is $28.6 billion, largely connected to his vaccine and healthcare businesses.
Cyrus Poonawalla Net Worth Quick Bio
| Profile | Details |
|---|---|
| Full Name | Cyrus Soli Poonawalla |
| Date of Birth | 11 May 1941 |
| Age | 85 years |
| Height | 5 ft 5 in (165 cm) |
| Birthplace | Pune, Maharashtra, India |
| Nationality | Indian |
| Profession | Businessman, entrepreneur and philanthropist |
| Famous For | Founder of Serum Institute of India |
| Current Role | Founder and Chairman of Serum Institute of India |
| Source of Wealth | Vaccines, biotechnology and healthcare businesses |
| Net Worth | Approximately $28.6 billion |
| Marital Status | Widowed |
| Wife | Villoo Poonawalla |
| Children | Adar Poonawalla |
| Parents | Soli Poonawalla and Gool Poonawalla |
| Sibling | Zavaray Poonawalla |
| Education | Brihan Maharashtra College of Commerce; Pune University |
| Honorary Degree | Honorary Doctor of Science, University of Oxford |
| Residence | Pune, India |
| Hair Color | Salt and pepper |
| Eye Color | Dark brown |
| Hobbies & Interests | Thoroughbred horses, horse racing and automobiles |
| Family Background | Thoroughbred horse breeding and racing |
| Serum Institute Founded | 1966 |
| Initial Business Focus | Biological products and therapeutic antisera |
| DTP Vaccine | Introduced in the 1970s |
| Measles Vaccine Production | Began in 1989 |
| WHO Export Accreditation | 1994 |
| International Vaccine Distribution | Vaccines supplied to numerous countries and international immunization programs |
| Annual Vaccine Production | More than 1.5 billion doses |
| COVID-19 Vaccine | Serum Institute manufactured Covishield |
| Padma Shri | 2005 |
| Padma Bhushan | 2022 |
| Oxford Recognition | Honorary Doctor of Science, 2019 |
| Johns Hopkins Recognition | Dean’s Medal, 2022 |
| Other Recognition | Lifetime achievement recognition from Savitribai Phule Pune University |
| Business Interests | Vaccines, biotechnology, financial services, hospitality, real estate and investments |
| Major Financial Business | Poonawalla Fincorp |
| Son | Adar Poonawalla |
| Son’s Profession | Businessman and CEO of Serum Institute of India |
| Grandchildren | 2 |
| No confidently verified personal account identified | |
| Career Began | 1966 |
| Years Active | 1966–present |
| Net Worth Status | Estimated figure that can change with business valuations and asset values |
Cyrus Poonawalla Images
A Timeline Cyrus Poonawalla
| Year | Milestone |
|---|---|
| 1941 | Cyrus Soli Poonawalla was born in Pune, Maharashtra. |
| 1946 | The Poonawalla family began breeding and racing thoroughbreds in India. |
| 1966 | Cyrus Poonawalla founded Serum Institute of India in Pune. |
| 1968 | Serum Institute introduced its therapeutic anti-tetanus serum. |
| 1974 | The company introduced its DTP vaccine. |
| 1981 | Serum Institute began producing anti-snake-venom serum. |
| 1989 | Production of the measles vaccine began. |
| 1994 | Serum Institute received WHO accreditation for vaccine exports. |
| 1998 | Serum Institute was exporting vaccines to more than 100 countries. |
| 2005 | Cyrus Poonawalla received the Padma Shri and the Sabin Humanitarian Award. |
| 2012 | Serum Institute acquired Bilthoven Biologicals in the Netherlands. |
| 2019 | Poonawalla received an Honorary Doctor of Science degree from Oxford University. |
| 2020–2021 | Serum Institute became a major manufacturer of Covishield, the Oxford-AstraZeneca COVID-19 vaccine in India. |
| 2022 | Poonawalla received the Padma Bhushan for his contribution to trade and industry. |
| 2022 | He received the Dean’s Medal from Johns Hopkins Bloomberg School of Public Health. |
| 2024 | Savitribai Phule Pune University honored him with a Lifetime Achievement Award. |
| 2026 | Poonawalla continues as Chairman and Managing Director of the Poonawalla Group and Serum Institute of India. |
Cyrus Poonawalla Family
| Family Member | Details |
|---|---|
| Father | Soli Poonawalla |
| Mother | Gool Poonawalla |
| Brother | Zavaray Poonawalla |
| Wife | Villoo Poonawalla |
| Son | Adar Poonawalla |
| Daughter-in-law | Natasha Poonawalla |
| Grandchildren | Darius Poonawalla and Cyrus Poonawalla |
| Family Business | Vaccines, biotechnology, finance, hospitality, real estate, aviation and thoroughbred horse breeding |
| Family Horse Business | The Poonawalla family has been involved in thoroughbred breeding and racing since 1946. |
| Current Family Business Leadership | Adar Poonawalla serves as CEO of Serum Institute of India. |
